Default Theme
AIIMS NEW
अखिल भारतीय आयुर्विज्ञान संस्थान, नई दिल्ली
All India Institute Of Medical Sciences, New Delhi
कॉल सेंटर:  011-26589142

Aruna Nambirajan

Full Name

Dr. Aruna Nambirajan

 

 

Qualifications

MD (Pathology), DNB

Office Address

3015, Third Floor, Convergence Block, AIIMS, New Delhi, 110029

Specialty

Pulmonary pathology (neoplastic and non-neoplastic), Cytopathology, Neuropathology

Areas of academic and research interest

Lung cancer, Molecular diagnostics, Pulmonary cytology, Non-neoplastic lung diseases, Thymic neoplasms, Digital pathology

Notable Awards and Honors

  • MBBS (Best Outgoing MBBS student, Chengelpet Govt. Medical College, Tamilnadu)
  • MD Pathology (Best Outgoing Junior Resident, AIIMS, New Delhi, Dr V Ramalingaswamy Gold Medal)
  • DNB Pathology (All India Topper, NBE President’s Gold Medal)
  • Dr V R Khanolkar Award, APCON, (2014)
  • ISNO (Indian Society of Neuro-oncology) President’s Annual award for best student in Clinical Neuro-Oncology, ISNOCON, Hyderabad, 2016
  • Colonel DB Nayar Memorial Award for best paper in the field of molecular cytopathology, AC of IAC, Shillong, 2017
  • Certificate of Excellence (Basic research Category), AIIMS foundation day, 2018- first author in winning publication
  • Young Investigator Travel award, International Congress of Neuropathology, Japan, 2018
  • AIIMS Oncology Award (Basic Research Category) 2nd place, 2019 – co-author in winning publication
  • AIIMS Oncology Award (Basic Research Category) 1st place, 2020 – first author in winning publication
  • Developing Nations Award – Winning Finalist, World Conference on Lung Cancer, Worldwide Virtual Event, 2021

Books and chapters

  • Nambirajan A., Jain D. (2021) Immunohistochemical Detection of p40 Expression in Lung Cancer Clinical Samples. In: Santiago-Cardona P.G. (eds) Lung Cancer. Methods in Molecular Biology, vol 2279. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1278-1_2
  • Nambirajan A, Singh V, Jain D. Molecular pathology of thymic epithelial tumors. In: Atlas of Thymic Pathology; Eds: Jain D, Bishop JA, Wick MR. Springer 2020: pgs. 169-172
  • Nambirajan A. (2020) Infectious diseases. In: Eds. Singh MK, Kumar V. Robbins and Cotran Pathologic Basis of Disease: Vol II, 10e - South Asia Edition, pgs. 1332-1333
  • Nambirajan A., Sharma A., Sharma M.C. (2021) Pathology and Molecular Pathology of Ependymoma. In: Mallick S., Giridhar P., Rath G.K. (eds) Evidence based practice in Neuro-oncology. Springer, Singapore. https://doi.org/10.1007/978-981-16-2659-3_4
  • Nambirajan A., Singh J., Suri V. (2021) Pathology and Molecular Pathology of Meningioma. In: Mallick S., Giridhar P., Rath G.K. (eds) Evidence based practice in Neuro-oncology. Springer, Singapore. https://doi.org/10.1007/978-981-16-2659-3_5
  • Giridhar P., Nambirajan A., Benson R. (2021) Ependymoma. In: Mallick S., Giridhar P., Rath G.K. (eds) Evidence based practice in Neuro-oncology. Springer, Singapore. https://doi.org/10.1007/978-981-16-2659-3_24
  • Suri V, Nambirajan A, Sharma MC, Sarkar C. Surgical Pathology of intractable epilepsy. In. Progress in clinical neurosciences, Volume 30; Eds: Muthukumar N and Goyal V, Thieme Delhi, 2016: pgs 13-32.
  • Nambirajan A, Sharma MC. Ependymal tumors. In. Essentials of Diagnostic Surgical Neuropathology; Eds: Sarkar C, Santosh V, Chacko G. Thieme Delhi 2018: pgs 41-49. 

Top Research publications

  1. Nambirajan A, Kaur H, Jangra K, et al. Adenocarcinoma predominant pattern subtyping and nuclear grading in cytology: Is there a role in prognostication of advanced pulmonary adenocarcinomas? Cytopathology. 2018;29:163-171. 
  2. Nambirajan A, Longchar M, Madan K, Mallick SR, Kakkar A, Mathur S, Jain D. Endobronchial ultrasound guided transbronchial needle aspiration cytology in patients with known or suspected extra-pulmonary malignancies: A cytopathology based study. Cytopathology. 2018;30:82-90.
  3. Nakra T, Nambirajan A, Guleria P, Phulware R, Jain D. Insulinoma-associated protein 1 is a robust nuclear immunostain for the diagnosis of small cell lung carcinoma in cytology smears. Cancer Cytopathol. 2019;127:539-548.
  4. Singh V, Nambirajan A, Malik PS, Thulkar S, Pandey RM, Luthra K, Arava S, Ray R, Mohan A, Jain D. Spectrum of uncommon and compound epidermal growth factor receptor mutations in non-small cell lung carcinomas with treatment response and outcome analysis: a study from India. Lung Cancer. 2020;149:53-60.
  5. Singh V, Nambirajan A, Malik PS, Kaur K, Mohan A, Jain D. EGFR mutation testing in cytology smears of advanced non-small cell lung carcinomas: practical applications in low resource laboratories. Cytopathology. 2021; 32:287-289.
  6. Nambirajan A, Singh V, Bhardwaj N, Mittal S, Kumar S, Jain D. SMARCA4/BRG1-deficient non-small cell lung carcinomas: a case series and review of the literature. Arch Pathol Lab Med. 2021;145:90-98.
  7. Nambirajan A, Dutta R, Malik PS, Bubendorf L, Jain D. Cytology of SMARCA4-deficient thoracic neoplasms: comparative analysis of SMARCA4-deficient non-small cell lung carcinomas and SMARCA4-deficient thoracic sarcomas. Acta Cytol. 2021;65:67-74.
  8. Satapathy S, Singh V, Nambirajan A, Malik PS, Tanwar P, Mehta A, Suryavanshi M, Thulkar S, Mohan A, Jain D. EGFR mutation testing on plasma and urine samples: A pilot study evaluating the value of liquid biopsy in lung cancer diagnosis and management. Curr Probl Cancer. 2021 Mar 3:100722. doi: 10.1016/j.currproblcancer.2021.100722. Epub ahead of print.
  9. Dutta R, Nambirajan A, Mittal S, Roy SC, Jain D. Cytomorphology of primary pulmonary NUT carcinoma in different cytology preparations. Cancer Cytopathol. 2021;129:53-61.
  10. Ray A, Jain D, Goel A, Agarwal S, Swaroop S, Das P, Arava SK, Mridha AR, Nambirajan A, Singh G, Arulselvi S, Mathur P, Kumar S, Sahni S, Nehra J, Nazneen, Bm M, Rastogi N, Mahato S, Gupta C, Bharadhan S, Dhital G, Goel P, Pandey P, Kn S, Chaudhary S, Keri VC, Chauhan VS, Mahishi N, Shahi A, R R, Gupta BK, Aggarwal R, Soni KD, Nischal N, Soneja M, Lalwani S, Sarkar C, Guleria R, Wig N, Trikha A. Clinico-pathological features in fatal COVID-19 infection: a preliminary experience of a tertiary care center in North India using postmortem minimally invasive tissue sampling. Expert Rev Respir Med. 2021 Jul 24:1-9. doi: 10.1080/17476348.2021.1951708.

Ongoing Research Projects

  • Molecular mechanisms of drug resistance in non-small cell lung carcinoma (AIIMS intramural collaborative – ongoing)
  • Corticotrope pituitary adenomas (ICMR funded – ongoing)
  • Spinal ependymomas (AIIMS funded – ongoing)

Links

https://www.ncbi.nlm.nih.gov/pubmed/?term=Nambirajan+A%5Bauthor%5D https://scholar.google.com/citations?user=JLJ-uBwAAAAJ&hl=en

https://www.researchgate.net/profile/Aruna-Nambirajan

Zo2 Framework Settings

Select one of sample color schemes

Google Font

Menu Font
Body Font
Heading Font

Body

Background Color
Text Color
Link Color
Background Image

Header Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Menu Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Main Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Inset Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Bottom Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image
Background Color
Modules Title
Text Color
Link Color
Background Image
 
Top of Page